Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 1998 Dec 7;12(3):150–153. doi: 10.1002/(SICI)1098-2825(1998)12:3<150::AID-JCLA4>3.0.CO;2-D

Immunohistochemical detection of MUC2 mucin core protein in ulcerative colitis

Yuji Hinoda 1,, Hirofumi Akashi 1, Takamaro Suwa 1, Fumio Itoh 1, Masaaki Adachi 1, Takao Endo 1, Masaaki Satoh 2, Pei Xiang Xing 3, Kohzoh Imai 1
PMCID: PMC6807796  PMID: 9591701

Abstract

MUC2 mucin is predominantly expressed in the colon and is considered to play an important role in the protection of that organ. Recent findings suggested that MUC2 protein levels are significantly decreased in active ulcerative colitis (UC). We therefore performed an immunohistochemical study to reveal if the expression of MUC2 protein is altered in UC. Seventy‐nine biopsy tissue specimens from 31 UC patients, along with normal colon tissues, were immunostained with anti‐MUC2 mucin core protein monoclonal antibody (MoAb) CCP58 (IgG1). UC tissue specimens were divided into two groups based on the histological severity of inflammation, i.e., 64 with active inflammation (grades 2–5) and 15 without (grade 1). In the former group, 52 out of 64 (81.3%) tissue specimens contained sections of glands with a few cells positive for MoAb CCP58. These glands were small and consisted of MUC2 negative‐short cells and a few positive cells without apparent mucus formation, considered to be immature regenerative glands. In contrast, the staining pattern was almost the same as that of the normal colon and no immature glands were seen in the group without active inflammation. The sections of immature regenerative glands with a few MUC2‐positive cells were exclusively found in the UC tissues with active inflammation, but not in those without it, suggesting that the expression of MUC2 protein may be decreased in active UC. J. Clin. Lab. Anal. 12:150–153, 1998. © 1998 Wiley‐Liss, Inc.

Keywords: ulcerative colitis, MUC2, mucin core protein, goblet cell

References

  • 1. Gum JR, Hicks JW, Toribara NW, Siddiki B, Kim YS: Molecular cloning of human intestinal mucin (MUC2) cDNA. J Biol Chem 269: 2440–2446, 1994. [PubMed] [Google Scholar]
  • 2. Ogata S, Uehara H, Chen A, Itzkowitz SH: Mucin gene expression in colonic tissues and cell lines. Cancer Res 52: 5971–5978, 1992. [PubMed] [Google Scholar]
  • 3. Devine PL, McGukin MA, Birrell GW, et al.: Monoclonal antibodies reacting with the MUC2 mucin core protein. Br J Cancer 67: 1182–1188, 1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Gambus G, Bolos CD, Andreu D, Franci C, Egea G, Real FX: Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody. Gastroenterology 104: 93–102, 1993. [DOI] [PubMed] [Google Scholar]
  • 5. Chang SK, Dohrman AF, Basbaum CB, et al.: Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 107: 28–36, 1995. [DOI] [PubMed] [Google Scholar]
  • 6. Ho SB, Niehans GA, Lyftogt CT, et al.: Heterogeneity of mucin gene exrpession in normal and malignant epithelial tissues. Cancer Res 53: 641–651, 1993. [PubMed] [Google Scholar]
  • 7. Kim YS, Byrd JC: Ulcerative colitis: A specific mucin defect? Gastroenterology 87: 1193–1195, 1984. [PubMed] [Google Scholar]
  • 8. Tysk C, Riedesel H, Lindberg E, Panzini B, Podolsky D, Jarnetot G: Clonic glycoproteins in monozygotic twins with inflammatory bowel disease. Gastroenterology 100: 419–423, 1991. [DOI] [PubMed] [Google Scholar]
  • 9. Weiss AA, Babyatsky MW, Ogata S, Chen A, Itzkowitz SH: Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem 44: 1161–1166, 1996. [DOI] [PubMed] [Google Scholar]
  • 10. Tygat KMA, Van der Wal JWG, Einerhand AWC, Buller HA, Dekker J: Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun 224: 397–405, 1996. [DOI] [PubMed] [Google Scholar]
  • 11. Xing PX, Prenzoska J, Layton GT, Devine PL, McKenzie IFC: Second‐generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J Natl Cancer Inst 84: 699–703, 1992. [DOI] [PubMed] [Google Scholar]
  • 12. Ohe Y, Hinoda Y, Irimura T, Imai K, Yachi A: Expression of sulfated carbohydrate chains detected by monoclonal antibody 91.9H in human gastric cancer tissues. Jpn J Cancer Res 85: 400–408, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Matts SGF: The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 120: 393–407, 1961. [PubMed] [Google Scholar]
  • 14. Specian RD, Oliver MG: Functional biology of intestinal goblet cells . Am J Physiol 260: C183–C193, 1991. [DOI] [PubMed] [Google Scholar]
  • 15. Hibi T, Ohara M, Kobayashi K, et al.: Enzyme‐linked immunosorbent assay (ELISA) and immunoprecipitation studies on antigoblet cell antibody using a mucin‐producing cell line in patients with inflammatory bowel disease. Gut 35: 224–320, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Folwaczny C, Noehl N, Tschop K, et al.: Goblet cell autoantibodies in patients with inflammatory bowel disease and their first‐degree relatives. Gastroenterology 113: 101–106, 1997. [DOI] [PubMed] [Google Scholar]
  • 17. Velcich A, Palumbo L, Jarry A, Laboisse C, Racevskis J, Augenlicht L: Patterns of expression of lineage‐specific markers during the in vitro‐induced differentiation of HT29 colon carcinoma cells. Cell Growth Differ 6: 749–757, 1995. [PubMed] [Google Scholar]
  • 18. Blank M, Klussman E, Kruger‐Krasagakes S, et al.: Expression of MUC2‐mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 59: 301–306, 1994. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES